Jensen Investment Team Sells Position in Becton Dickinson
The investment team has chosen to sell long-term holding Becton Dickinson (BDX) from the Jensen Quality Growth Strategy due to the company’s return on equity (ROE) falling below our 15% threshold in its most recent fiscal year.
Becton Dickinson is a leading global supplier of medical devices and equipment. Key business segments include needles and syringes, catheters, and infusion pumps.
We retain a positive view on Becton Dickinson’s business. However, the company’s ROE was impaired by a series of equity issuances over the past several years. To qualify for our investible universe, a company must continue to achieve a 15% ROE each year for 10 consecutive years as determined by the investment team. We began reducing the position in late 2022 and sold the remaining stake in July 2023.
Strategy holdings are subject to change and should not be considered recommendations to buy or sell any security.
The discussion of the specific security identified in this article is solely intended to illustrate the application of our investment approach. Our views expressed herein are subject to change and should not be construed as investment advice and are not designed or intended as a basis or determination for making any investment decision for any security. This information is current as of the date of this material and is subject to change at any time, based on the market and other conditions. Past performance is no guarantee of future results.
Jensen Investment Management, Inc., is an investment adviser registered under the Investment Advisers Act of 1940. Registration with the SEC does not imply any level of skill or training.
© 2023 Jensen Investment Management
Jensen News & Insights
The Jensen investment team sold United Parcel Service (UPS) shares from the Quality Growth Strategy to take advantage of better opportunities within the Portfolio.
Jensen Portfolio Manager Tyra Pratt, CFA, was named a “Rising Star” at the Fund Intelligence Mutual Fund Industry and ETF Awards 2023.
KLA, a semiconductor production equipment manufacturer, was added to the Jensen Quality Growth and Global Quality Growth Strategies in June 2023.
While inflation feels more tolerable now than it did in 2022, it is still high. As the storm clouds have not fully dispersed, at Jensen, we counsel investors to remain vigilant — and their advisors even more so.
A banking crisis has caused a big headache for investors in early 2023, but our Quality Value investment approach may provide a tonic.
How can advisers put the current market environment in perspective to help their clients prepare for whatever comes next?
Jensen Portfolio Manager Kevin Walkush joins the Animal Spirits Podcast to discuss quality growth investing, active management, return on equity, and more.
Pfizer stands to lose approximately $17B in sales over the next several years due to the loss of exclusivity on several large drug franchises. Find out why we believe this short-term noise may not outweigh the benefits for long-term investors.